1 Aboge G O, Jia H, Terkawi M A, et al. Cloning, expression, and characterization of Babesia gibsoni dihydrofolate reductase-thymidylate synthase: Inhibitory effect of antifolates on its catalytic activity and parasite proliferation[J]. Antimicrob Agents Chemother,2008,52(11):4072~4080. 2 Aboulaila M, Nakamura K, Govind Y, et al. Evaluation of the in vitro growth-inhibitory effect of epoxomicin on Babesia parasites[J]. Vet Parasitol,2010a,167(1):19~27. 3 AbouLaila M, Sivakumar T, Yokoyama N, et al. Inhibitory effect of terpene nerolidol on the growth of Babesia parasites[J]. Parasitol Int,2010,59(2):278~282. 4 Aboulaila M, Yokoyama N, Igarashi I. Inhibitory effects of (-)-epigallocatechin-3-gallate from green tea on the growth of Babesia parasites[J]. Parasitology,2010b,137(5):785~791. 5 Bartlett S L, Abou-Madi N, Messick J B, et al. Diagnosis and treatment of Babesia odocoilei in captive reindeer (Rangifer tarandus tarandus) and recognition of three novel host species[J]. J Zoo Wildl Med,2009,40(1):152~159. 6 Baumeister S, Wiesner J, Reichenberg A, et al. Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways[J]. PLoS One,2011,6(5):e19334. 7 Bork S, Yokoyama N, Matsuo T, et al. Clotrimazole, ketoconazole, and clodinafop-propargyl inhibit the in vitro growth of Babesia bigemina and Babesia bovis (Phylum Apicomplexa)[J]. Parasitology,2003,127(Pt 4):311~315. 8 Bork S, Okamura M, Boonchit S, et al. Identification of Babesia bovis L-lactate dehydrogenase as a potential chemotherapeutical target against bovine babesiosis[J]. Mol Biochem Parasitol,2004,136(2):165~172. 9 Bork S, Das S, Okubo K, et al. Effects of protein kinase inhibitors on the in vitro growth of Babesia bovis[J]. Parasitology,2006,132(Pt6):775~779. 10 Bork S, Yokoyama N, Hashiba S, et al. A sexual growth of Babesia bovis is inhibited by specific sulfated glycoconjugates[J]. J Parasitol,2007,93(6):1501~1504. 11 Caballero M C, Pedroni M J, Palmer G H, et al. Characterization of acyl carrier protein and LytB in Babesia bovis apicoplast[J]. Mol Biochem Parasitol,2012,181(2):125~133. 12 Goo Y K, Terkawi M A, Jia H, et al. Artesunate, a potential drug for treatment of Babesia infection[J]. Parasitol Int,2010,59(3):481~486. 13 Gubernot D M, Lucey C T, Lee K C, et al. Babesia infection through blood transfusions: Reports received by the US Food and Drug Administration, 1997—2007[J]. Clinical Infectious Diseases,2009,48(1):25~30. 14 Haddad M, Sauvain M, Deharo E. Curcuma as a parasiticidal agent: A review[J]. Planta Medica,2011,77(6):672~678. 15 Hwang S J, Yamasaki M, Nakamura K, et al. Development and characterization of a strain of Babesia gibsoni resistant to diminazene aceturate in vitro[J]. J Vet Med Sci,2010,72(6):765~771. 16 Iguchi A, Matsuu A, Ikadai H, et al. Development of in vitro atovaquone-resistant Babesia gibsoni with a single-nucleotide polymorphism in cytb[J]. Vet Parasitol,2012,185(2~4):145~150. 17 Ikadai H, Tanaka T, Shibahara N, et al. Inhibitory effect of lactoferrin on in vitro growth of Babesia caballi[J]. Am J Trop Med Hyg,2005,73(4):710~712. 18 Jomaa H, Wiesner J, Sanderbrand S, et al. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs[J]. Science,1999,285(5433):1573~1576. 19 Kumar S, Gupta A K, Pal Y, et al. In vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys[J]. J Vet Med Sci,2003,65(11):1171~1177. 20 Lin E C, Chueh L L, Lin C N, et al. The therapeutic efficacy of two antibabesial strategies against Babesia gibsoni[J]. Vet Parasitol,2012,186(3~4):159~164. 21 McHardy N, Woollon R M, Clampitt R B, et al. Efficacy, toxicity and metabolism of imidocarb dipropionate in the treatment of Babesia ovis infection in sheep[J]. Res Vet Sci,1986,41(1):14~20. 22 Nakamura K, Yokoyama N, Igarashi I. Cyclin-dependent kinase inhibitors block erythrocyte invasion and intraerythrocytic development of Babesia bovis in vitro[J]. Parasitology,2007,134 (Pt10):1347~1353. 23 Nehrbass-Stuedli A, Boykin D, Tidwell R R, et al. Novel diamidines with activity against Babesia divergens in vitro and Babesia microti in vivo[J]. Antimicrob Agents Chemother,2011,55(7):3439~3445. 24 Okubo K, Yokoyama N, Govind Y, et al. Babesia bovis: Effects of cysteine protease inhibitors on in vitro growth[J]. Exp Parasitol,2007,2(117):214~217. 25 Richier E, Biagini G A, Wein S, et al. Potent antihematozoan activity of novel bisthiazolium drug T16: Evidence for inhibition of phosphatidylcholine metabolism in erythrocytes infected with Babesia and Plasmodium spp[J]. Antimicrob Agents Chemother,2006,50(10):3381~3388. 26 Tsuji N, Battsetseg B, Boldbaatar D, et al. Babesial vector tick defensin against Babesia sp. parasites[J]. Infect Immun,2007,75(7):3633~3640. 27 Vander Jagt D L, Deck L M, Royer R E. Gossypol: Prototype of inhibitors targeted to dinucleotide folds[J]. Curr Med Chem,2000,7(4):479~498. 28 Yamasaki M, Tamura N, Nakamura K, et al. Effects and mechanisms of action of polyene macrolide antibiotic nystatin on Babesia gibsoni in vitro[J]. J Parasitol,2011,97(6):1190~1192. |